GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/IBD/Ultraprocessed Grains Increase IBD Risk: AJG | June 2026
25

Ultraprocessed Grains Increase IBD Risk: AJG | June 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated June 1, 2026
  • This large prospective PURE study evaluated the relationship between ultraprocessed grain consumption and the future development of inflammatory bowel disease across 124,590 participants from 21 countries.
  • Ultraprocessed grains include heavily refined grain products that often contain additives, emulsifiers, preservatives, flavour enhancers, and other industrial ingredients.
  • Higher consumption of ultraprocessed grains was associated with a significantly increased risk of developing IBD.
  • Individuals consuming ≥19 g/day of ultraprocessed grains had nearly double the risk of IBD compared with those consuming less than 9 g/day.
  • The association remained significant after adjustment for major confounders, including age, sex, smoking, dietary habits, and physical activity.
  • The findings support growing evidence linking Westernised dietary patterns and food processing to intestinal inflammation.
  • In contrast, consumption of fresh bread and rice was associated with a lower risk of developing IBD.
  • The study also confirmed a broader dietary signal: higher overall intake of ultraprocessed foods was strongly associated with future IBD development.
  • Participants consuming five or more servings of ultraprocessed foods daily had almost a fourfold higher risk of IBD compared with those consuming less than one serving per day.
  • Several biological mechanisms may explain the findings, including:

Alteration of gut microbiota

Increased intestinal permeability

Disruption of the mucus barrier

Exposure to food additives and emulsifiers

Enhanced mucosal immune activation

  • The study adds further support to the hypothesis that environmental and dietary factors contribute substantially to the rising global incidence of IBD.
  • Although observational, the prospective design and multinational nature of the PURE cohort strengthen the validity of the findings.
  • The study cannot identify which specific component of ultraprocessed grains is responsible for the increased risk, and further mechanistic research is needed.
  • From a clinical perspective, dietary counselling aimed at reducing ultraprocessed food consumption may become an increasingly important component of IBD prevention strategies.

Bottom line: Higher consumption of ultraprocessed grains is associated with a significantly increased risk of developing IBD, while less processed staple foods, such as fresh bread and rice, appear to be associated with lower risk. The findings reinforce the importance of minimising ultraprocessed foods as part of a gut-healthy dietary pattern

Related Q&A

26

HLA-DRB1*01:03 Identifies a Severe IBD Phenotype : Lancet Gastroenterol Hepatol | June 2026

Introduction: Inflammatory bowel disease (IBD) exhibits marked heterogeneity in disease behavior, progression, and treatment response. Identifying genetic markers associated with aggressive disease could facilitate earlier risk stratification and...

27

Ustekinumab and Anti-TNFs Show Comparable Efficacy After Vedolizumab Failure : GETAID | June 2026

Introduction: Vedolizumab has become a widely used first-line advanced therapy for ulcerative colitis (UC) because of its favorable efficacy and safety profile. However, a substantial proportion of patients...

28

Metastatic Crohn’s Disease Often Precedes Intestinal Diagnosis : Gut | June 2026

Introduction: Metastatic Crohn’s disease (MCD), also referred to as cutaneous or genital Crohn’s disease, is a rare extraintestinal manifestation characterized by granulomatous skin inflammation occurring at sites separate...

29

Darvadstrocel in Complex Perianal Crohn’s Disease: Gastroenterology | June 2026

Darvadstrocel is an allogeneic adipose-derived mesenchymal stem cell therapy designed to promote fistula healing through anti-inflammatory and immunomodulatory mechanisms. It is administered locally into conditioned fistula tracts after...

30

Inflammaging and Sarcopenia: Nutrients | June 2026

Inflammaging and sarcopenia are two interconnected hallmarks of aging that contribute to frailty, disability, metabolic dysfunction, loss of independence, and reduced quality of life. Inflammaging refers to chronic...

31

Managing C. difficile Infection in Patients With IBD: Gastroenterology | May 2026

Clostridioides difficile infection (CDI) remains one of the most important triggers of disease flares, hospitalization, treatment failure, colectomy, and mortality in patients with inflammatory bowel disease. Every patient...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer